Arbutus Return On Equity from 2010 to 2024
| ABUS Stock | USD 3.46 0.01 0.29% |
Return On Equity | First Reported 2010-12-31 | Previous Quarter (0.69) | Current Value (0.65) | Quarterly Volatility 0.7463335 |
Check Arbutus Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arbutus Biopharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 701.5 K or Selling General Administrative of 12.2 M, as well as many indicators such as Price To Sales Ratio of 13.01, Dividend Yield of 0.0529 or PTB Ratio of 3.72. Arbutus financial statements analysis is a perfect complement when working with Arbutus Biopharma Valuation or Volatility modules.
Arbutus | Return On Equity |
Latest Arbutus Biopharma's Return On Equity Growth Pattern
Below is the plot of the Return On Equity of Arbutus Biopharma Corp over the last few years. Return on Equity is the amount of Arbutus Biopharma Corp net income returned as a percentage of Arbutus Biopharma equity. Return on equity measures Arbutus Biopharma profitability by revealing how much profit Arbutus Biopharma Corp generates with the money shareholders have invested. It is a measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity. Arbutus Biopharma's Return On Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arbutus Biopharma's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported -0.68 | 10 Years Trend |
|
Return On Equity |
| Timeline |
Arbutus Return On Equity Regression Statistics
| Arithmetic Mean | (0.68) | |
| Geometric Mean | 0.59 | |
| Coefficient Of Variation | (109.45) | |
| Mean Deviation | 0.51 | |
| Median | (0.51) | |
| Standard Deviation | 0.75 | |
| Sample Variance | 0.56 | |
| Range | 2.845 | |
| R-Value | (0.07) | |
| Mean Square Error | 0.60 | |
| R-Squared | 0 | |
| Significance | 0.80 | |
| Slope | (0.01) | |
| Total Sum of Squares | 7.80 |
Arbutus Return On Equity History
About Arbutus Biopharma Financial Statements
Arbutus Biopharma shareholders use historical fundamental indicators, such as Return On Equity, to determine how well the company is positioned to perform in the future. Although Arbutus Biopharma investors may analyze each financial statement separately, they are all interrelated. The changes in Arbutus Biopharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on Arbutus Biopharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Return On Equity | (0.69) | (0.65) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Arbutus Stock Analysis
When running Arbutus Biopharma's price analysis, check to measure Arbutus Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arbutus Biopharma is operating at the current time. Most of Arbutus Biopharma's value examination focuses on studying past and present price action to predict the probability of Arbutus Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arbutus Biopharma's price. Additionally, you may evaluate how the addition of Arbutus Biopharma to your portfolios can decrease your overall portfolio volatility.